RxDoctor Payments Data

Antonette Scott

Nurse Practitioner · Winston Salem, NCNPI 1700558434

Payments from drug & device makers

$1,265in general payments, 2019–2025

Across 58 payments — averaging $21.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • GSK$199
  • Genentech USA, Inc.$103
  • Pfizer$102
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$99
  • AbbVie$89
  • Lilly USA, LLC$87
  • plus $586 from 18 others

What the payments were for

  • Food & beverage$1,265100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,265 in reported general payments places this provider in the 80th percentile of 4,393 nurse practitioner providers in North Carolina.

See all nurse practitioner providers in North Carolina

Medicare billing

Part B allowed, 2024
$10,774
Medicare patients
55
Services billed
187

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide28$50,377
JanuviaSitagliptin Phosphate15$21,428
EliquisApixaban21$18,647
JardianceEmpagliflozin11$9,985
VascepaIcosapent Ethyl21$5,586
Humulin 70/30 KwikpenInsulin Nph Hum/Reg Insulin Hm13$1,624
Atorvastatin Calcium250$1,537
Clonidine13$1,364
Albuterol Sulfate HfaAlbuterol Sulfate52$1,316
Hydrocortisone18$1,034
Gabapentin86$1,022
Omeprazole68$954
Ventolin HfaAlbuterol Sulfate16$921
Amlodipine Besylate204$908
Fluticasone Propionate60$847

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$71$50,37728 claims
PfizerEliquis$102$18,64721 claims
Boehringer IngelheimJardiance$34$9,98511 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 4,393 nurse practitioner providers in North Carolina.

Other nurse practitioner in Winston Salem

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →